Leadership

Officers

Dr. John Keller (President)
President & CEO
Shionogi Inc.

Dr. William Mann (Vice President)
President & CEO
Helsinn Therapeutics (U.S.) Inc.

Ms. Brianne Weingarten (Secretary)
Head of Alliance Management
Licensing & Business Development
Purdue Pharma

Mr. Shoji Yasuda (Treasurer)
President
Taisho Pharmaceutical R&D Inc.

Additional Members of
The Board of Directors

Mr. Tim Whitten
Chief Operating Officer
Taiho Oncology, Inc.

Ms. Theresa Covert
AVP Business Development/Developed Markets
Global Human Health
Merck & Co., Inc.

Mr. Mark Dennish
Vice President, Business Development, New Product Planning & Oncology
Daiichi Sankyo Inc.

Dr. Thomas Heffner 
Executive Director, Global Business Development
Pfizer Inc.

Dr. John Keller
President & CEO
Shionogi Inc.

Mr. Sang Le
Senior Director of Alliance Management
Otsuka America Pharmaceuticals

Dr. William Mann
President & CEO
Helsinn Therapeutics (U.S.) Inc.

Mr. Takeshi Masuda
President & CEO
Kyowa Kirin USA Holdings, Inc.

Dr. Blaine McKee
Head of Transactions
Shire

Dr. Hiroshi Kawai
Vice President, Business Development
Mitsubishi Tanabe Pharma Holdings America, Inc.

Ms. June Nguyen
Executive Director, Corporate Strategy
Eisai Inc.

Mr. Kazumi Taguchi 
President
Kyorin USA Inc.

Ms. Brianne Weingarten
Head of Alliance Management
Licensing and Business Development
Purdue Pharma L.P.

Mr. Shoji Yasuda
President
Taisho Pharmaceutical R&D Inc.

Special Advisor

Mr. Hiroyuki Kawabata
Director, Health and Welfare Dept.
JETRO New York